P00533 (EGFR_HUMAN) Homo sapiens (Human)
Epidermal growth factor receptor UniProtKBInterProSTRINGInteractive Modelling
Available Structures
323 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| The Extracellular and Transmembrane Domain Interfaces in Epidermal Growth Factor Receptor Signaling |
Heteromer P01133; | 99.84 | 12×NAG; 5×2PE; | |||
| Nanobody EgB4 bound to the full extracellular EGFR-EGF complex |
Heteromer P01133; | 100 | 14×NAG; | |||
| Cryo-EM structure of the extracellular module of the full-length EGFR L834R bound to EGF. "tips-sep… |
Heteromer P01133; | 99.84 | ||||
| Cryo-EM structure of the extracellular module of the full-length EGFR bound to TGF-alpha. "tips-jux… |
Heteromer P01135; | 99.84 | ||||
| Cryo-EM structure of the extracellular module of the full-length EGFR bound to EGF "tips-juxtaposed… |
Heteromer P01133; | 99.84 | ||||
| Cryo-EM structure of the extracellular module of the full-length EGFR bound to TGF-alpha "tips-sepa… |
Heteromer P01135; | 99.84 | ||||
| Cryo-EM structure of the extracellular module of the full-length EGFR L834R bound to EGF. "tips-jux… |
Heteromer P01133; | 99.84 | ||||
| Cryo-EM structure of the extracellular module of the full-length EGFR bound to EGF. "tips-separated… |
Heteromer P01133; | 99.84 | ||||
| The complex structure of extracellular domain of EGFR and GC1118A |
Heteromer | 100.0 | 1×NAG; 2×NAG; 1×NAG; | |||
| Structure of the extracellular domain of the epidermal growth factor receptor in complex with the F… |
Heteromer | 99.51 | 1×NAG; 3×NAG; 5×NAG; | |||
| Crystal structure of the extracellular domain of the epidermal growth factor receptor in complex wi… |
Heteromer | 100 | 2×NAG; 1×NAG; 1×NAG; 2×NAG; | |||
| Structure of the extracellular domain of human epidermal growth factor (EGF) receptor in an inactiv… |
Heteromer P01133; | 99.84 | 2×NAG; 1×NAG; 5×NAG; | |||
| The complex structure of extracellular domain of EGFR with Repebody (rAC1). |
Heteromer E0ACT6; Q4G1L3; | 100 | 1×NAG; 2×NAG; | |||
| Crystal structure of the complex of 059-152-Fv and EGFR-ECD |
Heteromer | 100 | 1×NAG; 7×NAG; 20×ZN; | |||
| Nanobody/VHH domain 9G8 in complex with the extracellular region of EGFR |
Heteromer | 100.0 | 2×NAG; 4×NAG; | |||
| Structure of Cetuximab Fab mutant in complex with EGFR extracellular domain |
Heteromer P0DOX5; Q8TCD0; | 99.67 | 1×NAG; 1×NAG; 3×NAG; | |||
| Nanobody/VHH domain EgA1 in complex with the extracellular region of EGFR |
Heteromer | 100.0 | 2×NAG; 3×NAG; | |||
| The EGF-bound EGFR ectodomain homodimer |
Heteromer P01133; | 100 | 2×NAG; 4×NAG; | |||
| The EGF-bound EGFR/HER2 ectodomain complex |
Heteromer P01133; P04626; | 100 | 1×NAG; 1×NAG; 2×NAG; | |||
| The EREG-bound EGFR/HER2 ectodomain complex |
Heteromer O14944; P04626; | 100 | 1×NAG; 1×NAG; 2×NAG; | |||
| Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domain… |
Heteromer P01133; | 100 | 1×NAG; 8×NAG; | |||
| Crystal Structure of Human Epidermal Growth Factor Receptor (residues 1-501) in complex with TGF-al… |
Heteromer P01135; | 100.0 | 1×NAG; 1×NAG; 1×NAG; 1×NAG; 7×PT; 11×CD; 4×CL; 1×NAG; | |||
| Crystal structure of the epidermal growth factor receptor extracellular region in complex with epir… |
Heteromer O14944; | 100 | 2×NAG; 1×NAG; 4×NAG; | |||
| Crystal structure of the epidermal growth factor receptor extracellular region with A265V mutation … |
Heteromer O14944; | 99.8 | 1×NAG; 1×NAG; | |||
| Crystal structure of the epidermal growth factor receptor extracellular region with R84K mutation i… |
Heteromer O14944; | 99.8 | 1×NAG; 1×NAG; 1×NAG; | |||
| Crystal structure of the epidermal growth factor receptor extracellular region in complex with epig… |
Heteromer Q6UW88; | 100.0 | 1×NAG; 2×NAG; | |||
| Crystal structure of the epidermal growth factor receptor extracellular region with R84K mutation i… |
Heteromer O14944; | 99.8 | 1×NAG; 5×NAG; 2×MAN; 1×BMA; | |||
| Crystal structure of the extracellular region of the epidermal growth factor receptor in complex wi… |
Heteromer Q6GMX6; | 100 | 1×NAG; 2×NAG; 2×NAG; | |||
| EGFR L858R MUTANT IN COMPLEX WITH A SHC PEPTIDE SUBSTRATE |
Heteromer P29353; | 99.68 | ||||
| Crystal structures of EGFR in complex with Mig6 |
Heteromer Q9UJM3; | 99.68 | ||||
| Crystal structures of EGFR in complex with Mig6 |
Heteromer Q9UJM3; | 99.68 | ||||
| Crystal structure of nanobody/VHH domain of 34E5 in complex with the extracellular region of the ep… |
Heteromer | 100 | 1×NAG; 1×NAG; | |||
| Crystal structure of L858R + T790M EGFR kinase domain in complex with MIG6 peptide |
Heteromer Q9UJM3; | 99.31 | ||||
| Crystal structure of the complex between the EGFR kinase domain and a Mig6 peptide |
Heteromer Q9UJM3; | 99.65 | 1×SO4; | |||
| Crystal structure of the complex between the EGFR kinase domain and a Mig6 peptide |
Heteromer Q9UJM3; | 99.65 | ||||
| Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-E… |
Heteromer P21860; | 99.66 | 1×ANP; 2×MG; 1×ADP; | |||
| Crystal structure of an EGFR/HER3 kinase domain heterodimer |
Heteromer P21860; | 99.66 | 1×ANP; 2×MG; 1×ADP; | |||
| Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-Q… |
Heteromer P21860; | 99.66 | 1×ANP; 2×MG; 1×ADP; | |||
| Crystal structure of the complex between the EGFR kinase domain and a Mig6 peptide |
Heteromer Q9UJM3; | 100.0 | ||||
| crystal structure of EGFR kinase domain in complex with Mitogen-inducible gene 6 protein |
Heteromer Q9UJM3; | 100.0 | ||||
| Nanobody/VHH domain 7D12 in complex with domain III of the extracellular region of EGFR, pH 6.0 |
Heteromer | 100 | 1×NAG; 2×MES; 2×NAG; 1×IOD; | |||
| anti-EGFR/HER3 Fab DL11 in complex with domain III of EGFR extracellular region |
Heteromer | 100 | 2×NAG; 1×NAG; 1×GOL; | |||
| Nanobody/VHH domain 7D12 in complex with domain III of the extracellular region of EGFR, pH 3.5 |
Heteromer | 100 | 1×NAG; 2×NAG; | |||
| Crystal structure of isolated domain III of the extracellular region of the epidermal growth factor… |
Heteromer Q6GMX6; | 100 | 1×NAG; 1×NAG; 2×NAG; 1×SO4; | |||
| Crystal Structure of panitumumab in complex with epidermal growth factor receptor domain 3 mutant S… |
Heteromer | 98.43 | 3×SO4; 2×GOL; 2×EDO; 1×1PE; | |||
| Crystal structure of the Fab fragment of necitumumab (Fab11F8) in complex with domain III from a ce… |
Heteromer | 99.47 | 1×NAG; 1×NAG; 2×NAG; | |||
| Crystal Structure of panitumumab in complex with epidermal growth factor receptor domain 3. |
Heteromer | 98.95 | 3×SO4; 1×GOL; 1×1PE; | |||
| Crystal structure the Fab fragment of matuzumab (Fab72000) in complex with domain III of the extrac… |
Heteromer | 100 | 4×NAG; 1×BMA; | |||
| Heterodimeric association of Transmembrane domains of ErbB1 and ErbB2 receptors Enabling Kinase Act… |
Heteromer P04626; | 100 | ||||
| Antibodies Specifically Targeting a Locally Misfolded Region of Tumor Associated EGFR |
Heteromer | 100 | ||||
| Antibodies Specifically Targeting a Locally Misfolded Region of Tumor Associated EGFR |
Heteromer | 100 | 2×ACT; 1×GOL; 3×FMT; | |||
| Crystal structure of c-Cbl TKB domain in complex with double phosphorylated EGFR peptide |
Heteromer P22681; | 100 | ||||
| Crystal structure of c-Cbl-TKB domain complexed with its binding motif in EGF receptor |
Heteromer P22681; | 100 | ||||
| Crystal structure of Cbl-b TKB domain in complex with EGFR pY1069 peptide |
Heteromer Q13191; | 100 | 1×NA; 2×CL; 4×SO4; 3×EDO; | |||
| Crystal structure of Cbl-c (Cbl-3) TKB domain in complex with EGFR pY1069 peptide |
Heteromer Q9ULV8; | 100 | 1×NA; 1×NI; | |||
| Crystal structure of the tyrosine kinase binding domain of Cbl-c in complex with phospho-EGFR pepti… |
Heteromer Q9ULV8; | 100 | 1×CA; | |||
| Crystal structure of the tyrosine kinase binding domain of Cbl-c (PL mutant) in complex with phosph… |
Heteromer Q9ULV8; | 100 | 1×CA; | |||
| Crystal structure of EGFR 696-1022 T790M in complex with LXX-6-26 | homo-4-mer | 99.67 | 4×816; 3×EDO; | |||
| Crystal structure of the EGF receptor juxtamembrane and kinase domains | homo-2-mer | 99.67 | ||||
| Crystal structure of mutated EGFR kinase domain (G719S) | homo-2-mer | 99.67 | ||||
| Crystal structure of EGFR double mutant (T790M/L858R) in complex with compound 6. | homo-2-mer | 99.34 | 2×35Z; | |||
| Crystal Structure of the active EGFR kinase domain in complex with an ATP analog-peptide conjugate | homo-2-mer | 100.0 | 2×CL; 2×112; | |||
| Crystal structure of EGFR kinase domain in complex with compound 3g | homo-2-mer | 100.0 | 2×KJR; | |||
| Crystal structure of EGFR kinase domain in complex with compound 2a | homo-2-mer | 100.0 | 2×KJQ; | |||
| Crystal structure of EGFR kinase domain in complex with compound 4c | homo-2-mer | 100.0 | 2×KJV; | |||
| Crystal structure of EGFR kinase domain in complex with compound 4b | homo-2-mer | 100.0 | 2×KJ8; | |||
| Crystal structure of EGFR 696-1022 T790M/C797S in complex with Go6976 | homo-2-mer | 99.34 | 1×85X; 2×CL; | |||
| Crystal structure of the wild-type EGFR kinase domain in complex with AMPPNP. | homo-2-mer | 100.0 | 2×ANP; | |||
| Crystal Structure of the active EGFR kinase domain | homo-2-mer | 100.0 | ||||
| Crystal structure of mutated EGFR kinase domain (L858R) in complex with AMPPNP | homo-2-mer | 99.66 | 2×ANP; | |||
| Crystal structure of EGFR T790M/C797S mutant in complex with brigatinib | homo-2-mer | 99.33 | 1×6GY; | |||
| EGFR in complex with a dihydrodibenzodiazepinone allosteric inhibitor. | homo-2-mer | 99.35 | 1×ANP; 2×O57; 3×MG; 1×AMP; 2×EDO; | |||
| Crystal structure of the mutated EGFR kinase domain (G719S/T790M) in complex with AMPPNP. | homo-2-mer | 99.33 | 2×ANP; | |||
| Crystal structure of the mutated EGFR kinase domain (G719S/T790M) in complex with gefitinib | homo-2-mer | 99.33 | 2×IRE; 2×MES; | |||
| Crystal structure of the mutated EGFR kinase domain (G719S/T790M) in the apo form | homo-2-mer | 99.32 | 2×MES; | |||
| EGFR L858R/T790M in complex with PD168393 | homo-2-mer | 99.31 | 2×YUN; | |||
| Crystal structure of EGFR 696-1022 T790M/V948R in complex with SKLB(6) | homo-2-mer | 99.34 | 2×7XU; | |||
| Crystal structure of EGFR 696-1022 T790M/V948R, crystal form II | homo-2-mer | 99.33 | 2×ANP; 2×MG; | |||
| EGFR kinase domain in complex with mutant selective allosteric inhibitor | homo-2-mer | 99.33 | 2×MG; 2×ANP; 1×57N; | |||
| Crystal structure of EGFR(T790M/V948R) in complex with LN3753 | homo-2-mer | 99.36 | 2×TOV; 1×CL; | |||
| Crystal Structure of the inactive EGFR kinase domain in complex with AMP-PNP | homo-2-mer | 99.64 | 2×MG; 11×IOD; 2×ANP; | |||
| Crystal structure of EGFR 696-1022 T790M/V948R in complex with SKLB(3) | homo-2-mer | 99.33 | 1×CL; 5×EDO; 1×7XO; 2×ANP; 3×MG; | |||
| EGFR(T790M/V948R) in complex with LN2057 | homo-2-mer | 99.36 | 2×CL; 2×QQJ; | |||
| EGFR(T790M/V948R) in complex with LN2899 | homo-2-mer | 99.36 | 2×CL; 2×EDO; 2×QP1; | |||
| EGFR(T790M/V948R) in complex with compound 1 (LN4503) | homo-2-mer | 99.32 | 2×MG; 2×ANP; | |||
| EGFR(T790M/V948R) in complex with LN2380 | homo-2-mer | 99.36 | 2×CL; 2×QQM; | |||
| EGFR(T790M/V948R) in complex with LN2725 | homo-2-mer | 99.36 | 2×QP4; 2×CL; | |||
| A crystal structure of EGFR(T790M/V948R) in complex with LN3754 | homo-2-mer | 99.33 | 2×ANP; 2×MG; | |||
| Crystal structure of EGFR with mutant-selective dihydrodibenzodiazepinone allosteric inhibitor | homo-2-mer | 99.33 | 2×ANP; 2×NQ1; 2×MG; | |||
| EGFR(T790M/V948R) in complex with Lazertinib (YH25448) | homo-2-mer | 99.33 | 1×ZRT; | |||
| EGFR with an allosteric inhibitor | homo-2-mer | 99.35 | 2×MG; 2×ANP; 2×JBJ; | |||
| Crystal structure of the inactive EGFR kinase domain in complex with AMP-PNP | homo-2-mer | 99.66 | 2×ANP; 2×MG; | |||
| EGFR kinase (T790M/V948R) in complex with allosteric inhibitor JBJ-09-063 | homo-2-mer | 99.33 | 2×MG; 2×ANP; 2×VNS; | |||
| EGFR kinase (T790M/V948R) in complex with osimertinib and JBJ-04-125-02 | homo-2-mer | 99.32 | 2×ANP; 2×MG; 2×JBJ; | |||
| EGFR kinase (T790M/V948R) in complex with osimertinib and EAI045 | homo-2-mer | 99.3 | 2×ANP; 2×MG; 1×9LL; | |||
| EGFR(T790M/V948R) in complex with LN2084 | homo-2-mer | 99.35 | 2×QP7; 2×CL; | |||
| EGFR kinase (T790M/V948R) in complex with AZ5104 | homo-2-mer | 99.3 | 2×VO7; | |||
| EGFR kinase (T790M/V948R) in complex with osimertinib and JBJ-09-063 | homo-2-mer | 99.31 | 2×YY3; 2×VNS; | |||
| EGFR L858R/V948R in complex with osimertinib and allosteric inhibitor JBJ-09-063 | homo-2-mer | 99.31 | 2×VNS; 2×YY3; | |||
| EGFR kinase (T790M/V948R) in complex with PF-06747775 | homo-2-mer | 99.29 | 2×8BS; | |||
| EGFR kinase (T790M/V948R) in complex with PF-06747775 and JBJ-04-125-02 | homo-2-mer | 99.32 | 1×ANP; 1×MG; 2×JBJ; 1×8BS; | |||
| EGFR kinase (L858R/V948R) in complex with allosteric inhibitor JBJ-09-063 | homo-2-mer | 99.31 | 2×MG; 2×ANP; 2×VNS; | |||
| EGFR(T790M/V948R) in complex with ZNL-0056 | homo-2-mer | 99.29 | 1×ZNL; | |||
| EGFR(T790M/V948R) in complex with compound 2 (LN5993) | homo-2-mer | 99.31 | 1×YAA; | |||
| Crystal structure of EGFR in complex with EAI045 | homo-2-mer | 99.31 | 2×MG; 2×ANP; 2×9LL; | |||
| Crystal Structure of EGFR_D770_N771insNPG/V948R in complex with TAK-788 | homo-2-mer | 99.64 | 2×R28; 1×EDO; 2×CIT; | |||
| EGFR transmembrane - juxtamembrane (TM-JM) segment in bicelles: MD guided NMR refined structure. | homo-2-mer | 96.43 | ||||
| Homodimeric transmembrane domain of the human receptor tyrosine kinase ErbB1 (EGFR, HER1) in micell… | homo-2-mer | 100 | ||||
| N-terminal motif dimerization of EGFR transmembrane domain in bicellar environment | homo-2-mer | 100 | ||||
| Crystal structure of EGFR 696-1022 T790M in complex with QL-X138 | monomer | 99.67 | 1×3LH; | |||
| Crystal structure of apo EGFR kinase domain | monomer | 100.0 | 1×MES; 2×SO4; | |||
| 1.85 angstrom structure of EGFR kinase domain with gefitinib | monomer | 100.0 | 1×IRE; 1×NA; 1×MES; | |||
| Crystal structure of EGFR_TMX in complex with covalently bound fragment 8 | monomer | 98.05 | 1×PE5; 1×N86; 1×DMS; | |||
| Crystal structure of EGFR_TMX in complex with covalently bound fragment 4 | monomer | 98.68 | 1×PE5; 1×MWU; 1×DMS; 3×CL; | |||
| Crystal structure of EGFR_DMX in complex with covalently bound fragment 4 | monomer | 98.37 | 1×PE5; 1×DMS; 1×MWU; | |||
| EGFR-T790M in complex with pyrazolopyrimidine inhibitor 1a | monomer | 99.66 | 1×6HJ; | |||
| Crystal Structure of EGFR-T790M/C797S in Complex with Brigatinib | monomer | 98.44 | 1×6GY; | |||
| Crystal structure of EGFR 696-1022 L858R in complex with AZD9291 | monomer | 99.69 | 1×YY3; | |||
| Tyrosine Kinase Domain from Epidermal Growth Factor Receptor | monomer | 100.0 | ||||
| EGFR-K IN COMPLEX WITH N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxy-phenyl] Pro… | monomer | 100.0 | 1×1WY; 1×NA; | |||
| Crystal structure of EGFR_TMX in complex with covalently bound compound 14 | monomer | 98.67 | 1×N9R; | |||
| Crystal Structure of EGFR-T790M/C797S in Complex with Reversible Aminopyrimidine 9 | monomer | 98.36 | 1×R25; 1×MES; | |||
| Crystal Structure of EGFR 696-1022 T790M Mutant Covalently Binding to WZ4002 | monomer | 99.68 | 1×0UN; | |||
| Crystal structure of EGFR kinase domain in complex with an irreversible inhibitor 34-jab | monomer | 100.0 | 1×DJK; | |||
| Crystal structure of EGFR kinase domain in complex with an irreversible inhibitor 13-jab | monomer | 100.0 | 1×CL; | |||
| Crystal structure of EGFR 696-1022 T790M in complex with WZ4003 | monomer | 99.68 | 1×0UN; | |||
| 1.9 angstrom structure of EGFR kinase domain | monomer | 100.0 | 1×NA; 1×MES; | |||
| Structure of EGFR in complex with MTX-531 | monomer | 100 | 1×GOL; 1×CL; 1×D0D; | |||
| EGFR kinase domain mutant "TMLR" with compound 41a | monomer | 99.33 | 1×SO4; 1×4ZQ; | |||
| Crystal structure of EGFR_DMX in complex with compound 7 | monomer | 98.37 | 1×PE5; 1×N7C; | |||
| Wild type EGFR in complex with LN2057 | monomer | 100.0 | 1×QQJ; | |||
| EGFR kinase in complex with Bayer #33 | monomer | 100.0 | 1×X9B; 2×CIT; | |||
| Crystal structure of EGFR_DMX in complex with covalently bound fragment 1 | monomer | 98.38 | 1×PE5; 1×N6N; 1×NA; | |||
| Crystal structure of EGFR_TMX in complex with covalently bound fragment 10 | monomer | 98.03 | 1×PE5; 1×N99; | |||
| EGFR kinase domain mutant "TMLR" with compound 23 | monomer | 99.33 | 1×SO4; 1×4YX; | |||
| EGFR kinase domain mutant "TMLR" with 3-carboxamide azaindole compound 13 | monomer | 99.34 | 1×SO4; 1×60D; | |||
| Crystal structure of EGFR kinase domain G719S mutation in complex with AMP-PNP | monomer | 99.67 | 1×MG; 1×ANP; | |||
| Crystal structure of EGFR kinase domain L858R mutation in complex with AMP-PNP | monomer | 99.67 | 1×ANP; | |||
| EGFR kinase in complex with a macrocyclic inhibitor | monomer | 100.0 | 1×M0R; 1×FLC; | |||
| Crystal Structure of EGFR-WT in Complex with TAK-788 | monomer | 100.0 | 1×R28; 1×MES; | |||
| Crystal structure of EGFR_TMX in complex with covalently bound fragment 12 | monomer | 98.04 | 1×PE5; 1×N9L; 1×DMS; | |||
| Discovery and Optimisation of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 In… | monomer | 100.0 | 1×2I0; | |||
| Discovery and Optimisation of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 In… | monomer | 100.0 | 1×2I6; | |||
| Crystal structure of the EGFR kinase domain in complex with 4-(4-{[2-{[(3S)-1-acetylpyrrolidin-3-yl… | monomer | 100.0 | 1×8BM; | |||
| Discovery of a Highly Potent and Broadly Effective EGFR and HER2 Exon 20 Insertion Mutant Inhibitor | monomer | 100.0 | 1×FZP; | |||
| EGFR(L858R/T790/C797S) in complex with compound 5j | monomer | 98.99 | 1×W7W; 1×CL; | |||
| EGFR in complex with a macrocyclic inhibitor | monomer | 100.0 | 1×M19; 1×FLC; | |||
| Epidermal Growth Factor Receptor tyrosine kinase domain with 4-anilinoquinazoline inhibitor erlotin… | monomer | 100.0 | 1×AQ4; | |||
| EGFR kinase domain mutant "TMLR" with 3-azetidinyl azaindazole compound 21 | monomer | 99.33 | 1×SO4; 1×60E; | |||
| Studies Towards a Reversible EGFR C797S Triple Mutant Inhibitor Series | monomer | 100.0 | 1×6GY; | |||
| Crystal structure of EGFR_TMX in complex with covalently bound fragment 9 | monomer | 99.0 | 1×PE5; 1×N8O; 1×DMS; | |||
| EGFR kinase in complex with pyrazolopyrimidine covalent inhibitor | monomer | 100.0 | 1×HZ6; | |||
| EGFR-KINASE IN COMPLEX WITH COMPOUND 5 | monomer | 99.33 | 1×L1K; 1×DMS; | |||
| EGFR kinase domain with compound 41a | monomer | 100.0 | 1×4ZQ; | |||
| EGFR kinase in complex with poziotinib | monomer | 100.0 | 1×R2E; 1×CIT; | |||
| Crystal structure of EGFR 696-1022 T790M in complex with XTF-262 | monomer | 99.67 | 1×F62; | |||
| Crystal structure of the wild-type EGFR kinase domain in complex with dacomitinib (soaked) | monomer | 100.0 | 1×1C9; | |||
| Crystal structure of EGFR kinase domain L858R mutation in complex with AFN941 | monomer | 99.67 | 1×ITQ; | |||
| Crystal structure of EGFR kinase domain L858R mutation in complex with Iressa | monomer | 99.67 | 1×CL; 1×IRE; | |||
| EGFR kinase domain mutant "TMLR" with compound 27 | monomer | 99.34 | 1×SO4; 1×4ZB; | |||
| Wild type EGFR in complex with LN2380 | monomer | 100.0 | 1×QQM; | |||
| EGFR kinase domain mutant "TMLR" with pyridone compound 13: 4-[(2-methoxyphenyl)amino]-~{N}-[4-(4-m… | monomer | 99.33 | 1×SO4; 1×5Q4; | |||
| Crystal structure of EGFR kinase domain in complex with compound 78 | monomer | 100.0 | 1×CKO; | |||
| EGFR kinase domain mutant "TMLR" with compound 28f | monomer | 99.33 | 1×NSO; | |||
| Crystal structure of EGFR 696-1022 L858R in complex with SKLB(3) | monomer | 99.67 | 1×7XO; 1×CL; | |||
| Crystal structure of EGFR 696-1022 T790M in complex with Go6976 | monomer | 99.65 | 1×85X; | |||
| Crystal structure of EGFR 696-1022 L858R in complex with SKLB(5) | monomer | 99.67 | 1×7XR; 1×CL; | |||
| Crystal structure of EGFR 696-1022 L858R in complex with SKLB(6) | monomer | 99.68 | 1×7XU; 1×CL; | |||
| Crystal structure of EGFR 696-1022 T790M in complex with JTS-1-39 | monomer | 99.69 | 1×81C; 4×EDO; 5×CL; | |||
| Crystal structure of EGFR kinase domain in complex with AEE788 | monomer | 100.0 | 1×AEE; | |||
| Crystal structure of EGFR kinase domain G719S mutation in complex with Iressa | monomer | 99.67 | 1×IRE; | |||
| Crystal Structure of EGFR T790M mutant in complex with naquotinib | monomer | 99.67 | 1×8RC; | |||
| Wild type EGFR in complex with LN2899 | monomer | 100.0 | 1×QP1; | |||
| Crystal Structure of EGFR(L858R/T790M/C797S) in complex with Osimertinib | monomer | 98.06 | 1×YY3; | |||
| EGFR kinase domain mutant "TMLR" with compound 41b | monomer | 99.33 | 1×SO4; 1×4ZR; | |||
| EGFR kinase in complex with mobocertinib (TAK-788) | monomer | 100.0 | 1×R28; | |||
| Crystal Structure of EGFR(L858R/T790M/C797S) in complex with CH7233163 | monomer | 98.01 | 1×EUX; | |||
| Crystal structure of EGFR 696-1022 T790M in complex with CO-1686 | monomer | 99.67 | 1×8JC; | |||
| Wild type EGFR in complex with Lazertinib (YH25448) | monomer | 100.0 | 1×ZRT; | |||
| EGFR kinase domain mutant "TMLR" with compound 30 | monomer | 99.34 | 2×SO4; 1×4ZH; | |||
| The crystal structure of EGFR T790M/C797S with the inhibitor HC5476 | monomer | 99.31 | 1×I0A; | |||
| EGFR L858R in complex with PD168393 | monomer | 99.67 | 1×DJK; 2×CL; | |||
| The crystal structure of EGFR T790M/C797S with the inhibitor HCD2892 | monomer | 98.72 | 1×7VH; | |||
| Crystal structure of EGFR 696-1022 T790M in complex with AZD9291 prepared by soaking | monomer | 99.68 | 1×YY3; | |||
| EGFR kinase domain mutant "TMLR" with compound 29 | monomer | 99.33 | 1×4ZG; | |||
| EGFR kinase domain mutant "TMLR" with a imidazopyridinyl-aminopyrimidine inhibitor | monomer | 99.34 | 1×SO4; 1×63N; | |||
| EGFR kinase domain mutant "TMLR" with azabenzimidazole compound 7 | monomer | 99.33 | 1×SO4; 1×60B; | |||
| EGFR kinase domain mutant "TMLR" with pyridone compound 2: 4-[2-(4-chlorophenyl)ethylamino]-~{N}-[4… | monomer | 99.33 | 1×5Q2; | |||
| Crystal structure of EGFR 696-1022 L858R in complex with CO-1686 | monomer | 99.66 | 1×8JC; | |||
| Crystal structure of EGFR kinase domain L858R mutation in complex with AEE788 | monomer | 99.67 | 1×AEE; | |||
| EGFR kinase domain mutant "TMLR" with pyridone compound 19: 4-[(2-azanylpyrimidin-4-yl)amino]-~{N}-… | monomer | 99.34 | 1×SO4; 1×5Q3; | |||
| The structure of co-crystals of 8r-B-EGFR WT complex | monomer | 100.0 | 1×C6O; | |||
| Crystal structure of EGFR_wt in complex with covalently bound fragment 4 | monomer | 100.0 | 1×MWU; | |||
| EGFR-T790M in complex with pyrazolopyrimidine inhibitor 1b | monomer | 99.67 | 1×6HL; | |||
| EGFR kinase domain with pyridone compound 13: 4-[(2-methoxyphenyl)amino]-~{N}-[4-(4-methylpiperazin… | monomer | 100.0 | 1×5Q4; | |||
| EGFR L858R MUTANT IN COMPLEX WITH AN OPTIMAL PEPTIDE SUBSTRATE | monomer | 99.68 | ||||
| EGFR kinase domain mutant "TMLR" with a pyrazolopyrimidine inhibitor | monomer | 99.36 | 1×63M; | |||
| Crystal structure of EGFR kinase domain in complex with AFN941 | monomer | 100.0 | 1×ITQ; | |||
| EGFR kinase domain mutant "TMLR" with compound 17 | monomer | 99.34 | 1×4YW; | |||
| The structure of co-crystals of 8r-B-EGFR T790M/C797S complex | monomer | 99.31 | 1×C6O; | |||
| Crystal structure of EGFR kinase domain in complex with AMP-PNP | monomer | 100.0 | 1×ANP; | |||
| EGFR kinase (T790M/L858R) with inhibitor compound 5 | monomer | 99.32 | 1×3QY; | |||
| Native-SAD phasing for human EGFR kinase domain. | monomer | 100.0 | ||||
| EGFR-KINASE IN COMPLEX WITH COMPOUND 1 | monomer | 99.31 | 1×L1H; | |||
| Crystal structure of EGFR kinase domain in complex with Iressa | monomer | 100.0 | 1×IRE; | |||
| EGFR T790M/C797S in complex with compound 6i | monomer | 99.33 | 1×9JO; | |||
| Crystal Structure of EGFR-T790M/C797S in Complex with WZ4002 | monomer | 98.42 | 1×0UN; 1×MES; | |||
| Crystal structure of EGFR kinase domain, Exon20 Insertion FQEA mutant | monomer | 100.0 | 2×PG4; 1×MG; 1×ANP; | |||
| Active conformation of EGFR kinase in complex with BI-4020 | monomer | 100.0 | 1×CL; 1×XA4; | |||
| EGFR kinase (T790M/L858R) with inhibitor compound 8 | monomer | 99.33 | 1×SO4; 1×3QS; | |||
| Ralimetinib (LY2228820) in complex with wild type EGFR | monomer | 100.0 | 1×YXT; | |||
| EGFR kinase domain mutant "TMLR" with compound 33 | monomer | 99.34 | 1×SO4; 1×4ZJ; | |||
| EGFR kinase (T790M/L858R) with inhibitor compound 1 | monomer | 99.32 | 1×SO4; 1×3R1; | |||
| Crystal Structure of EGFR-T790M/C797S in Complex with Covalent Pyrrolopyrimidine 19h | monomer | 98.4 | 1×MES; 1×L0N; | |||
| EGFR kinase (T790M/L858R) with inhibitor compound 27: ~{N}-(1~{H}-indazol-3-yl)-7,7-dimethyl-2-(2-m… | monomer | 99.33 | 1×5N4; | |||
| Studies Towards a Reversible EGFR C797S Triple Mutant Inhibitor Series | monomer | 100.0 | 1×R85; | |||
| Crystal structure of EGFR 696-1022 T790M/C797S in complex with LS_2_40 | monomer | 99.31 | 1×JAU; | |||
| EGFR-KINASE IN COMPLEX WITH COMPOUND 6 | monomer | 99.33 | 1×L3Z; 1×DMS; | |||
| Crystal structure of EGFR kinase domain G719S mutation in complex with AFN941 | monomer | 99.67 | 1×ITQ; | |||
| EGFR kinase (T790M/L858R) with inhibitor compound 4 | monomer | 99.33 | 1×SO4; 1×3R0; | |||
| EGFR kinase domain mutant "TMLR" with compound 24 | monomer | 99.33 | 1×4Z8; | |||
| EGFR kinase domain T790M mutant in complex with a covalent aminobenzimidazole inhibitor. | monomer | 99.65 | 1×5X4; | |||
| Crystal structure of EGFR kinase domain G719S mutation in complex with AEE788 | monomer | 99.67 | 1×AEE; | |||
| EGFR kinase (T790M/L858R) with inhibitor compound 6 | monomer | 99.33 | 1×3QW; | |||
| EGFR kinase (T790M/L858R) with inhibitor compound 15: ~{N}-(7-chloranyl-1~{H}-indazol-3-yl)-7,7-dim… | monomer | 99.33 | 1×5N3; | |||
| EGFR kinase in complex with TAS6417 (CLN-081) | monomer | 100.0 | 1×X9H; 1×CIT; | |||
| EGFR kinase (T790M/L858R) apo | monomer | 99.32 | ||||
| EGFR kinase domain mutant "TMLR" with compound 1 | monomer | 99.33 | 1×4YV; | |||
| Crystal structure of EGFR 696-1022 L858R in complex with FIIN-3 | monomer | 99.67 | 1×FI3; | |||
| The crystal structure of EGFR(T797M/L858R) with small molecule inhibitor B6 | monomer | 99.34 | 1×SO4; 1×VUZ; | |||
| EGFR kinase domain (L858R/V948R) in complex with 2-[4-(difluoromethyl)-6-[2-[4-[[4-(hydroxymethyl)-… | monomer | 99.29 | 1×EDO; 1×MES; 1×KXY; | |||
| EGFR Kinase domain T790M/L858R mutant with compound 2 | monomer | 99.35 | 1×W2P; | |||
| Crystal Structure of wild type EGFR in complex with TAK-788 | monomer | 100.0 | 1×R28; | |||
| Crystal structure of EGFR 696-1022 T790M/C797S in complex with D3003 | monomer | 99.32 | 1×9JO; 1×CL; | |||
| EGFR kinase domain in complex with a covalent aminobenzimidazole inhibitor. | monomer | 100.0 | 1×5X4; | |||
| Crystal Structure of EGFR-T790M/C797S in Complex with Covalent Pyrrolopyrimidine 19g | monomer | 98.39 | 1×L0Q; 1×MES; | |||
| Crystal structure of EGFR kinase in complex with BIBW2992 | monomer | 100.0 | 1×0WN; 2×0WM; | |||
| Crystal structure of EGFR kinase domain T790M mutation in complex with AEE788 | monomer | 99.67 | 1×AEE; | |||
| Crystal structure of EGFR kinase domain T790M mutation | monomer | 99.67 | ||||
| Crystal structure of EGFR kinase T790M in complex with BIBW2992 | monomer | 99.67 | 1×0WN; | |||
| Crystal structure the extracellular region of the epidermal growth factor receptor variant III (EGF… | monomer | 100 | 1×NAG; 2×NAG; | |||
| EGFR KINASE DOMAIN IN COMPLEX WITH A COVALENT AMINOBENZIMIDAZOLE | monomer | 99.66 | 1×5XH; | |||
| EGFR kinase domain in complex with 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-[6-[2-[4-[[4-(h… | monomer | 100.0 | 1×KY9; 1×SO4; | |||
| EGFR Kinase domain T790M/L858R mutant with compound 4 | monomer | 99.33 | 1×W2R; 1×EDO; | |||
| EGFR kinase domain T790M/L858R mutant with HKI-272 | monomer | 99.35 | 1×HKI; 1×MES; | |||
| EGFR Kinase domain T790M/L858R Mutant with TAK-285 | monomer | 99.34 | 1×03P; | |||
| AZD9291 complex with wild type EGFR | monomer | 100.0 | 1×YY3; | |||
| EGFR kinase domain mutant (T790M/L858R) with covalent ligand NS-062 | monomer | 99.31 | 1×8LU; | |||
| EGFR kinase domain with compound4 | monomer | 100.0 | 1×W2R; 2×SO4; | |||
| EGFR kinase domain complexed with compound 19b | monomer | 100.0 | 1×W19; 1×SO4; | |||
| Crystal structure of EGFR 696-1022 T790M in complex with Ibrutinib | monomer | 99.67 | 1×1E8; | |||
| EGFR Kinase domain complexed with tak-285 | monomer | 100.0 | 3×SO4; 1×03P; | |||
| EGFR kinase domain complexed with compound 20a | monomer | 100 | 1×W32; 1×SO4; | |||
| EGFR kinase domain complexed with a quinazoline inhibitor- GW572016 | monomer | 100.0 | 2×PO4; 1×FMM; | |||
| Crystal structure of the EGFR kinase domain mutant V924R | monomer | 99.67 | 1×ANP; 1×MG; | |||
| Crystal structure of the EGFR kinase domain mutant I682Q | monomer | 99.67 | 1×ANP; 1×MG; | |||
| Crystal structure of EGFR 696-1022 T790M/V948R in complex with SKLB(5) | monomer | 99.34 | 3×EDO; 1×7XR; | |||
| Discovery and Optimisation of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 In… | monomer | 99.67 | 1×26X; | |||
| Structure of the monomeric (V948R)gefitinib/erlotinib resistant double mutant (L858R+T790M) EGFR ki… | monomer | 98.99 | 1×IRE; 2×SO4; | |||
| Structure of T790M EGFR kinase domain co-crystallized with dacomitinib | monomer | 99.66 | 1×1C9; | |||
| Structure of EGFR in complex with hydrazone, a potent dual inhibitor | monomer | 100.0 | 2×PO4; 1×HYZ; | |||
| X-ray structure of EGFR in complex with oxime inhibitor | monomer | 100.0 | 2×PO4; 1×POX; | |||
| EGFR(T790M/V948R) in complex with LN3844 | monomer | 99.31 | 1×UEJ; | |||
| Crystal Structure of EGFR LRTM with compound 24 | monomer | 99.04 | 4×GOL; 1×QFO; | |||
| Crystal structure of the kinase domain of EGFR exon-19 (del-747-749) mutant | monomer | 100 | ||||
| EGFR(T790M/V948R) kinase in complex with osimertinib and benzimidazole allosteric inhibitor | monomer | 99.32 | 1×Q6K; 1×YW5; | |||
| Crystal Structure of EGFR LRTM with compound 7 | monomer | 99.03 | 1×GOL; 1×QCR; | |||
| Crystal structure the extracellular region of the epidermal growth factor receptor variant III (EGF… | monomer | 100 | 1×NAG; 2×NAG; | |||
| EGFR(T790M/V948R) in complex with AZD9291 and DDC4002 | monomer | 99.32 | 1×Q6K; 1×NQ1; | |||
| EGFR (T790M/V948R) in complex with quinazolinone allosteric inhibitor | monomer | 99.31 | 1×ANP; 1×MG; 1×YFA; | |||
| EGFR(T790M/V948R) kinase in complex with benzimidazole allosteric inhibitor | monomer | 99.31 | 1×MG; 1×ANP; 1×YW5; | |||
| Inactive conformation of EGFR (T790M/V948R) kinase in complex with BI-4020 | monomer | 99.32 | 1×XA4; | |||
| EGFR(T790M/V948R) in complex with LN5461 | monomer | 99.32 | 1×MG; 1×ANP; | |||
| EGFR(T790M/V948R) kinase in complex with poziotinib | monomer | 99.34 | 1×R2E; | |||
| EGFR(T790M/V948R) in complex with a macrocyclic inhibitor | monomer | 99.3 | 1×M1O; | |||
| EGFR (T79M/V948R) in complex with naquotinib and an allosteric inhibitor | monomer | 99.29 | 1×VNS; 1×8RC; | |||
| EGFR(T790M/V948R) in complex with the allosteric inhibitor FRF-06-057 | monomer | 99.29 | 1×MG; 1×ANP; 1×IXR; | |||
| EGFR D770_N771insNPG in complex with PD168393 | monomer | 100 | 1×YUN; | |||
| EGFR (L858R, T790M, V948R) in complex with N-{3-[(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-7H-py… | monomer | 99.01 | 1×633; 1×SO4; 1×GOL; | |||
| Crystal structure of EGFR tyrosine kinase domain with novel inhibitor of active state of HER2 | monomer | 99.67 | 2×SO4; 1×6JS; | |||
| EGFR (L858R, T790M, V948R) in complex with N-[3-({2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,… | monomer | 99.0 | 1×634; 2×SO4; 1×GOL; | |||
| Discovery and Optimisation of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 In… | monomer | 99.64 | 1×2II; | |||
| Crystal structure of EGFR kinase domain in complex with a sulfonyl fluoride probe XO44 | monomer | 98.96 | 1×O44; 1×SO4; 1×GOL; | |||
| EGFR kinase domain (L858R/V948R) in complex with 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-[… | monomer | 99.27 | 1×KY9; | |||
| Crystal structure of EGFR 696-988 T790M in complex with LXX-6-34 | monomer | 99.64 | 1×80U; 11×NO3; 19×EDO; 2×CL; | |||
| Crystal structure of EGFR 696-1022 T790M in complex with AZD9291 prepared by co-crystallization | monomer | 99.65 | 3×YY3; 3×CL; | |||
| Crystal structure of EGFR 696-1022 WT in complex with AZD9291 prepared by cocrystallization | monomer | 99.3 | 1×YY3; 1×CL; | |||
| Crystal structure of the monomeric (V948R) form of the gefitinib/erlotinib resistant EGFR kinase do… | monomer | 98.95 | ||||
| Crystal structure of monomeric (V948R) primary oncogenic mutant L858R EGFR kinase domain | monomer | 99.3 | ||||
| Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 21a | monomer | 99.25 | 1×N78; 2×EDO; 2×SO4; | |||
| Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 18b | monomer | 99.26 | 1×N7Q; 2×EDO; 2×SO4; | |||
| Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 21b | monomer | 99.25 | 1×N82; 1×EDO; 3×SO4; | |||
| Discovery and Optimisation of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 In… | monomer | 99.64 | 1×2EI; 20×IOD; | |||
| EGFR kinase domain in complex with 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-[6-[2-[4-[[4-(h… | monomer | 100.0 | 3×EDO; 1×KY9; 2×NO3; | |||
| Crystal Structure of EGFR-T790M/V948R in Complex with Spebrutinib and EAI001 | monomer | 99.25 | 1×57N; 1×7G9; 2×SO4; 1×CL; | |||
| Crystal Structure of EGFR-T790M/V948R in Complex with TAK-788 | monomer | 99.25 | 1×R28; | |||
| Crystal Structure of EGFR-T790M/V948R in Complex with Reversible Aminopyrimidine 13 | monomer | 99.26 | 1×V58; 2×SO4; 2×CL; | |||
| Crystal structure of EGFR kinase domain T790M mutation in compex with HKI-272 | monomer | 99.63 | 1×HKI; | |||
| Crystal structure of the EGFR kinase domain (L858R, T790M, V948R) in complex with a covalent inhibi… | monomer | 98.93 | 1×8AM; 2×SO4; 3×GOL; 1×EDO; | |||
| Crystal structure of the EGFR kinase domain (L858R, T790M, V948R) in complex with a covalent inhibi… | monomer | 98.93 | 1×8BP; 2×SO4; 4×GOL; | |||
| Crystal structure of the EGFR kinase domain (L858R, T790M, V948R) in complex with a covalent inhibi… | monomer | 98.93 | 1×8BS; 2×SO4; 3×GOL; 1×EDO; | |||
| Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 18c | monomer | 99.25 | 1×N7Z; 2×SO4; | |||
| Crystal Structure of EGFR-T790M/V948R in Complex with Poziotinib | monomer | 99.26 | 1×R2E; 2×SO4; 3×EDO; | |||
| Crystal Structure of EGFR-T790M/V948R in Complex with Mavelertinib and EAI001 | monomer | 99.26 | 1×8BS; 2×SO4; | |||
| EGFR (L858R, T790M, V948R) in complex with 1-[(3R,4R)-3-[({2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-p… | monomer | 98.93 | 1×63A; 2×SO4; 3×GOL; | |||
| Crystal structure of EGFR 675-1022 T790M/C797S/V948R in complex with EAI045 | monomer | 98.88 | 1×9LL; | |||
| Crystal structure of the EGFR kinase domain (L858R, T790M, V948R) in complex with 4-(4-{[2-{[(3S)-1… | monomer | 98.94 | 1×8BM; 2×SO4; 3×GOL; | |||
| EGFR (L858R, T790M, V948R) in complex with 1-{(3R,4R)-3-[5-Chloro-2-(1-methyl-1H-pyrazol-4-ylamino)… | monomer | 98.93 | 1×630; 1×SO4; | |||
| Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 18d | monomer | 99.25 | 1×N7W; 2×SO4; 1×MG; 1×CL; | |||
| Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 14d | monomer | 99.25 | 1×N7K; 2×SO4; | |||
| Crystal Structure of EGFR-T790M/V948R in Complex with Osimertinib and EAI045 | monomer | 99.26 | 1×Q6K; 1×9LL; 6×SO4; | |||
| Crystal structure of EGFR kinase domain (L858R, T790M, V948R) in complex with the covalent inhibito… | monomer | 98.89 | 1×8OV; | |||
| Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib. | monomer | 99.64 | 1×Q6K; 1×EDO; | |||
| Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 19 | monomer | 99.24 | 1×N7B; 4×SO4; | |||
| Crystal Structure of EGFR-T790M/V948R in Complex with LDC8201 | monomer | 99.29 | 4×SO4; 1×R1W; | |||
| Optimisation of Potent, Efficacious, Selective and Blood-Brain Barrier Penetrating Inhibitors Targe… | monomer | 99.63 | 1×A1H7N; 15×IOD; | |||
| Crystal structure of the inactive EGFR tyrosine kinase domain with erlotinib | monomer | 99.64 | 1×AQ4; | |||
| Optimisation of Potent, Efficacious, Selective and Blood-Brain Barrier Penetrating Inhibitors Targe… | monomer | 99.63 | 1×A1H7O; | |||
| EGFR kinase domain complexed with an imidazo[2,1-b]thiazole inhibitor | monomer | 99.62 | 1×ITI; | |||
| Discovery and Optimisation of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 In… | monomer | 99.63 | 1×26X; | |||
| A Structural Model for the Membrane-Bound Form of the Juxtamembrane Domain of the Epidermal Growth … | monomer | 100 | ||||
| Spatial structure of EGFR transmembrane and juxtamembrane domains in DPC micelles | monomer | 100 | ||||
| Crystal structure of human GABARAP fused to EGFR (1076-1099) | monomer | 100 | 1×CL; 1×GOL; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7syd.1.C | monomer | 0.77 | 99.92 | |||
| 3bbt.1.A | monomer | 0.72 | 1×FMM; | 77.85 | ||
5 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 3qwq.1.A | monomer | 0.82 | 99.75 | |||
| Isoform 3 | 3qwq.1.A | monomer | 0.81 | 98.74 | |||
| Isoform 3 | 7sye.1.A | monomer | 0.77 | 99.68 | |||
| Isoform 4 | 3qwq.1.A | monomer | 0.82 | 100.00 | |||
| Isoform 4 | 7sz0.1.C | monomer | 0.80 | 99.84 | |||